Stay updated on Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated: v3.4.2 was removed and v3.4.3 was added to the page.
    Difference
    0.0%
    Check dated 2026-03-12T03:30:28.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page shows a new site revision, v3.4.2, and the prior funding-status notice (v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:54:39.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice regarding government funding and the NIH Clinical Center's operating status was added, and the page revision was updated to v3.4.1, while the core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:44:30.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' label while removing the older 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' label, and the previous revision note; these are minor administrative/UI updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:30:02.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.3 to v3.3.4. No core study details or eligibility criteria appear to be changed.
    Difference
    0.0%
    Check dated 2026-01-14T02:38:42.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section updated to include Florida as a study site under Locations, with the dedicated Florida Locations subsection removed; the HHS Vulnerability Disclosure link has also been removed.
    Difference
    0.2%
    Check dated 2025-12-23T13:37:33.000Z thumbnail image

Stay in the know with updates to Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page.